New advanced imaging technology that detects specific molecules in the brain may find signs of MS lesions months earlier, a ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

The multiple sclerosis (MS) disease-modifying therapy (DMT) market across the seven major markets (7MM: the US, France, ...

Panelists discuss how robust clinical evidence from major studies like the EPIC and OPERA trials demonstrates that ...

Two new biomarkers—the kappa free light chains index and central vein sign—have been added to the McDonald criteria, ...

Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...

The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is ...

Recent highlights in MS coverage focus on biomarkers, pregnancy, and neurodegeneration. Physician’s Weekly has compiled a ...

Society Lancaster, Morecambe & Bay have announced a new partnership which aims to support individuals affected by an MS ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.